Thus, when considering patient eligibility in treatment protocols for advanced HCC, liver reserve appears to be a relevant factor, whereas extrahepatic metastasis, patient age, initial tumor size, serum AFP level, and degree of portal vascular invasion are not. Here, AFP is linked to neoplasm.